Smoking cessation program with exercise improves cardiovascular disease biomarkers in sedentary women

Journal of Women's Health

Volumn 20, Issue 7, 2011, Pages 1051-1064

  Korhonen, Tellervo ^a   Goodwin, Amy ^b   Miesmaa, Petra ^b   Dupuis, Elizabeth A ^c   Kinnunen, Taru ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; NICOTINE; PROTHROMBIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ERYTHROCYTE COUNT; EXERCISE; EXERCISE INTENSITY; FEMALE; HEALTH PROGRAM; HEART RATE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; NICOTINE REPLACEMENT THERAPY; OXYGEN CONSUMPTION; OXYGEN TENSION; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SEDENTARY LIFESTYLE; SMOKING CESSATION; THROMBOCYTE COUNT; WEIGHT GAIN;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMBINED MODALITY THERAPY; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; RISK REDUCTION BEHAVIOR; SEDENTARY LIFESTYLE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; WOMEN'S HEALTH; YOUNG ADULT;

EID: 79960242666     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2075     Document Type: Article

References (64)

1. Bullen C. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease. Expert Rev Cardiovasc Ther 2008;6:883-895.
2. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tobacco Res 2006;8:169-191. (Pubitemid 43675073)
3. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: The Framingham Study. Am Heart J 1987;113:1489-1494. (Pubitemid 17092823)
4. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103:1245-1249. (Pubitemid 32221347)
5. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.
6. Ward KD, Bliss RE, Vokonas PS, Garvey AJ. Effects of smoking cessation on blood pressure. Am J Cardiol 1993;72: 979-981. (Pubitemid 23298084)
7. Hatsukami DK, Kotlyar M, Allen S, et al. Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 2005;128:2528-2537. (Pubitemid 41507604)
8. Kannel WB, DAgostino RB, Belanger AJ. Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study. Am H J 1987;113:1006-1010. (Pubitemid 17052190)
9. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999;93:271-278. (Pubitemid 29143551)
10. Grines CL, Topol EJ, ONeill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995;91:298-303.
11. Horne BD, Anderson JL, John JM, et al., Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-1643. (Pubitemid 40704499)
12. Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 1999;84:1018-1022. (Pubitemid 29505368)
13. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131: 1557-1566. (Pubitemid 46762366)
14. Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: A meta-analysis. Prev Med 2003;37:283-290. (Pubitemid 37162679)
15. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events: Potential mediating mechanisms. Circulation 2007;116:2110-2118. (Pubitemid 350060348)
16. Gaillard TR, Sherman WM, Devor ST, Kirby TE, Osei K. Importance of aerobic fitness in cardiovascular risks in sedentary overweight and obese African-American women. Nurs Res 2007;56:407-415.
17. Cabrera de Leon A, Rodriguez-Perez Mdel C, Rodriguez- Benjumeda LM, et al. Sedentary lifestyle: Physical activity duration versus percentage of energy expenditure. Rev Espan Cardiol 2007;60:244-250. (Pubitemid 46691788)
18. Foster C. Central circulatory adaptations to exercise training in health and disease. Clin Sports Med 1986;5:589-604.
19. Fagard RH. Prescription and results of physical activity. J Cardiovasc Pharmacol 1995;25 (Suppl 1):S20-27.
20. Halbert JA, Silagy CA, Finucane P, Withers RT, Hamdorf PA. Exercise training and blood lipids in hyperlipidemic and normolipidemic adults: A meta-analysis of randomized, controlled trials. Eur J Clin Nutr 1999;53:514-522. (Pubitemid 29352182)
21. Fontana L, Villareal DT, Weiss EP, et al., and the Washington University School of Medicine CALERIE Group. Calorie restriction or exercise: Effects on coronary heart disease risk factors. A randomized, controlled trial. Am J Physiol.Endocrinol Metab 2007;293:E197-202.
22. Kraus WE, Houmard JA, Duscha BD, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med 2002;347:1483-1492. (Pubitemid 35257587)
23. Branch JD 3rd, Pate RR, Bourque SP, Convertino VA, Durstine JL, Ward DS. Exercise training and intensity does not alter vascular volume responses in women. Aviat Space Environ Med 1999;70:1070-1076. (Pubitemid 30042988)
24. Wang JS, Jen CJ, Chen HI. Effects of exercise training and deconditioning on platelet function in men. Arterioscl Thromb Vasc Biol 1995;15:1668-1674.
25. Imhof A, Koenig W. Exercise and thrombosis. Cardiol Clin 2001;19:389-400. (Pubitemid 32852076)
26. Myint PK, Luben RN, Wareham NJ, Welch AA, Bingham SA, Khaw KT. Physical activity and fibrinogen concentrations in 23,201 men and women in the EPIC-Norfolk population- based study. Atherosclerosis 2008;198:419-425. (Pubitemid 351707381)
27. Mayer-Davis EJ, DAgostino R Jr, Karter AJ, et al. Intensity and amount of physical activity in relation to insulin sensitivity: The Insulin Resistance Atherosclerosis Study. JAMA 1998;279:669-674. (Pubitemid 28138735)
28. Fiore M, United States. Tobacco Use and Dependence Guideline Panel. Treating tobacco use and dependence. Rockville, Md: U.S. Dept. of Health and Human Services, Public Health Service, 2000.
29. American College of Sports Medicine, Franklin BA, Whaley MH, Howley ET, Balady GJ. ACSMs guidelines for exercise testing and prescription, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2000.
30. Brinton TJ, Walls ED, Chio SS. Validation of pulse dynamic blood pressure measurement by auscultation. Blood Pressure Monitoring 1998;3:121-124. (Pubitemid 28288606)
31. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tobacco Res 2003;5:13-25. (Pubitemid 36285465)
32. Berlin I, Radzius A, Henningfield JE, Moolchan ET. Correlates of expired air carbon monoxide: Effect of ethnicity and relationship with saliva cotinine and nicotine. Nicotine Tobacco Res 2001;3:325-331. (Pubitemid 33101059)
33. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tobacco Res 2002;4:149-159.
34. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10: 141-146.
35. Doherty K, Militello FS, Kinnunen T, Garvey AJ. Nicotine gum dose and weight gain after smoking cessation. J Consult Clin Psychol 1996;64:799-807. (Pubitemid 26274543)
36. Garvey AJ, Kinnunen T, Nordstrom BL, et al. Effects of nicotine gum dose by level of nicotine dependence. Nicotine Tobacco Res 2000;2:53-63.
37. Kinnunen T, Leeman RF, Korhonen T, et al. Exercise as an adjunct to nicotine gum in treating tobacco dependence among women. Nicotine Tobacco Res 2008;10:689-703. (Pubitemid 351566555)
38. Broms U, Silventoinen K, Lahelma E, Koskenvuo M, Kaprio J. Smoking cessation by socioeconomic status and marital status: The contribution of smoking behavior and family background. Nicotine Tobacco Res 2004;6:447-455. (Pubitemid 38967533)
39. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86: 1119-1127.
40. Pauly JR. Gender differences in tobacco smoking dynamics and the neuropharmacological actions of nicotine. Front Biosci 2008;13:505-516. (Pubitemid 351599761)
41. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P 3rd. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther 2006;79:480-488.
42. Hill T, Lewicki P. Statistics methods and applications. Tulsa OK: StatSoft, 2007.
43. Eliasson B, Hjalmarson A, Kruse E, Landfeldt B, Westin A. Effect of smoking reduction and cessation on cardiovascular risk factors. Nicotine Tobacco Res 2001;3:249-255. (Pubitemid 32821652)
44. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Changes in hemorheological and biochemical parameters following short-term and long-term smoking cessation induced by nicotine replacement therapy (NRT). Int J Clin Pharmacol Ther 2004;42:83-92. (Pubitemid 38219919)
45. Crook MA, Scott DA, Stapleton JA, Palmer RM, Wilson RF, Sutherland G. Circulating concentrations of C-reactive protein and total sialic acid in tobacco smokers remain unchanged following one year of validated smoking cessation. Eur J Clin Invest 2000;30:861-865.
46. Hastie CE, Haw S, Pell JP. Impact of smoking cessation and lifetime exposure on C-reactive protein. Nicotine Tobacco Res 2008;10:637-642. (Pubitemid 351566549)
47. Mora S, Lee I-M, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and tra-ditional cardiovascular biomarkers in women. JAMA 2006; 295:1412-1419.
48. Van Tiel E, Peeters PH, Smit HA, et al. Quitting smoking may restore hematological characteristics within five years. Ann Epidemiol 2002;12:378-388. (Pubitemid 34823636)
49. Lewis MJ, Balaji G, Dixon H, Syed Y, Lewis KE. Influence of smoking abstinence and nicotine replacement therapy on heart rate and QT time-series. Clin Physiol Funct Imaging 2010;30:43-50.
50. Janzon E, Hedblad B, Berglund G, Engstrom G. Changes in blood pressure and body weight following smoking cessation in women. J Intern Med 2004;255:266-272. (Pubitemid 38241371)
51. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: A cohort study. Ann Intern Med 2010;152:10-17.
52. Nordström BL, Kinnunen T, Utman CH, Garvey AJ. Longterm effects of nicotine gum on weight gain after smoking cessation Nicotine Tobacco Res 1999;1:259-268.
53. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008;87:801-809. (Pubitemid 351549222)
54. U.S. Department of Health and Human Services (USDHHS). The Surgeon Generals report on physical activity and health. U.S. Department of Health and Human Services, Center for Chronic Disease Prevention and Health Promotion, 1996.
55. Burns DM. Epidemiology of smoking-induced cardiovascular disease. Prog Cardiovasc Dis 2003;46:11-29. (Pubitemid 37013217)
56. Catanzaro DF, Zhou Y, Chen R, et al. Potentially reduced exposure cigarettes accelerate atherosclerosis: Evidence for the role of nicotine. Cardiovasc Toxicol 2007;7:192-201. (Pubitemid 47575004)
57. Benowitz NL. Basic cardiovascular research and its implications for the medicinal use of nicotine. J Am Coll Cardiol 2003;41:497-498. (Pubitemid 36164509)
58. Heeschen C, Weis M, Cooke JP. Nicotine promotes arteriogenesis. J Am Coll Cardiol 2003;41:489-496. (Pubitemid 36164508)
59. Hellerstein MK, Benowitz NL, Neese RA, et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994;93:265-272. (Pubitemid 24030845)
60. Campbell SC, Moffatt RJ, Stamford BA. Smoking and smoking cessation-The relationship between cardiovascular disease and lipoprotein metabolism: A review. Atherosclerosis 2008;201:225-235.
61. Leeman RF, Quiles ZN, Molinelli LA, et al. Attrition in a multi-component smoking cessation study for females. Tobacco Induced Dis 2006;3:59-71.
62. McCarthy DE, Piasecki TM, Lawrence DL, Jorenby DE, Shiffman S, Baker TB. Psychological mediators of bupropion sustained-release treatment for smoking cessation. Addiction 2008;103:1521-1533.
63. MacPherson L, Stipelman, BA, Duplinsky M, Brown RA, Lejuez CW. Distress tolerance and pre-smoking treatment attrition: Examination of moderating relationships. Addict Behav 2008;33:1385-1393.
64. Reichert V, Xue X, Bartscherer D, et al. A pilot study to examine the effects of smoking cessation on serum markers of inflammation in women at risk for cardiovascular disease. Chest 2009;136:212-219.